Showing 1,098 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows

News
16 January 2018
Hepatitis C treatment

India to launch national program to control viral hepatitis and aims to negotiate lower drug prices

Editor's pick
Pharma Letter
9 January 2018
Hepatitis C treatment

England: 25,000 Hepatitis C patients receive new treatments

Editor's pick
NHS England
8 January 2018
Hepatitis C treatment

HCV Genotype 6 Responds to 8-Week Oral Treatment

Editor's pick
MD
2 January 2018
Hepatitis C treatment

Should uninfected patients accept hepatitis C-infected livers to reduce waiting time?

Editor's pick
Eurekalert Inf Dis
20 December 2017
Hepatitis C treatment

Hepatitis C treatment for people with HIV

About HIV
December 2017
Hepatitis C treatment

MSF: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region

Editor's pick
UNIAN
4 December 2017
Hepatitis C treatment

Gilead prices hepatitis C giant Sovaldi in China at one-fifth the US price: report

Editor's pick
FiercePharma
29 November 2017
Hepatitis C treatment

More work and lower drug prices are needed to eliminate hepatitis C worldwide

News
29 November 2017
Hepatitis C treatment

Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV

News
28 November 2017
Hepatitis C treatment

Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis

News
1 November 2017
Hepatitis C treatment

Nine countries now on track to eliminate hepatitis

Editor's pick
World Hepatitis Summit
1 November 2017
Access to healthcare

MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug

Editor's pick
Intellectual Property Watch
31 October 2017
Hepatitis C treatment

Close to 3 million people access hepatitis C cure

Editor's pick
World Health Organization
31 October 2017
Pharmaceutical industry

Gilead HCV drug sales down in 2017 third quarter compared with 2016

Editor's pick
Healio
31 October 2017
Hepatitis C treatment

More than 6 million treated for hepatitis globally

Editor's pick
Healio
31 October 2017
Hepatitis C treatment

Hepatitis C test-and-treat programme reduces HCV by two-thirds among men who have sex with men in Swiss HIV Cohort

News
30 October 2017
Hepatitis C treatment

Curing hepatitis C with DAAs linked to 71% reduction in liver cancer

News
30 October 2017
Hepatitis C treatment

Hepatitis C halved in Spanish people living with HIV in one year due to treatment

News
27 October 2017
Treatment guidelines

New EACS treatment guidelines

News
26 October 2017
Pharmaceutical industry

Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty

Editor's pick
Intellectual Property Watch
26 October 2017
Hepatitis C treatment

Maviret cures most people with HCV genotype 3 and those with cirrhosis

News
24 October 2017
Harm reduction

Screening for Hepatitis C Improves Opioid Abuse Treatment Outcomes

Editor's pick
AASLD
23 October 2017
Hepatitis C treatment

Hepatitis C cure leads to improved quality of life

News
23 October 2017